Andrew Satz: Expediting the U.S. Drug Approval Process

How do we expedite the drug approval process in the United States? Co-Founder & CEO of EVQLV, Andrew Satz, educates us on how and what is needed to do so. To find out more about Andrew, please find him on LinkedIn here: https://www.linkedin.com/in/andrewsatz/ To find out more about EVQLV, please find the company website here: https://evqlv.com/ Key takeaways: 1. The acceleration of getting drugs to patients by decreasing costs for researchers, industry, and other key stakeholder...